Try our Advanced Search for more refined results
Life Sciences - February, 2017
320 articles
- Lincare Dodges FCA Claims But Not Retaliation Allegations
- Health Care Fund Seeks Class Cert. In Celexa, Lexapro MDL
- Fed. Circ. Says PTAB Wrongly Nixed Patent In Eli Lilly Case
- FDA Warning Wire: Cardboard Parts Found In Pfizer Vials
- Pfizer Sues Ex-Marketing Director Over Trade Secret Theft
- 9th Circ. Won't Revive Spine Device False Claims Act Suit
- FDA Finally Addresses Interchangeable Biosimilars
- Cutting Labeling Regs May Harm Companies' Bottom Lines
- Complying With Expanded Access Policy Drug Laws
- How 401(k) Benefits Can Attract Millennial Legal Talent
- GC Whistleblowing And Other Implications From Bio-Rad
- How The Courts Review Executive Orders
- Conn. Man Cops To Bribery Over NJ Medical Device Contract
- Fresenius Dialysis Drug Didn't Kill Patient, Jury Told
- Cause Of Death Testimony OK'd In Meningitis Outbreak Trial
- Medical Supply Wholesaler Faces TCPA Suit Over Junk Faxes
- Perrigo Inks $2.85B Divestiture Amid Activist Pressure
- Feds Blast Drug Return Co.'s 'Puffery' Defense In $116M Fraud
- Eli Lilly, Pfizer Urge Fed. Circ. To Undo Sanofi IP Ruling
- Lab Exec Fights 'Hitler' Comparison In FCA Retaliation Suit
- South Texas Woman Convicted In $2.5M Medicaid Fraud
- When The Learned Intermediary Is A Physician's Assistant
- High Court's Patent Guidance On Exporting Component Parts
- Supreme Court Won't Hear 'Flanax' Foreign Trademark Case
- The Loss Of Confidentiality In NY Arbitral Enforcement Cases
- US Weighs In On High Court Biosimilars Battle
- Hernia Patch Death Suit Tossed For Lack Of Experts
- Cynosure Investors Sue To Block $1.4B Hologic Merger
- Animal Groups Sue Over 'Orwellian' Removal Of USDA Docs
- PTAB Invalidates 2 Anacor Patents In Hedge Fund Challenge
- Insurer Needn't Cover Catalent's $10M Shutdown Loss Claim
- 'Black-Box Medicine' Faces Headwinds Over Med Mal Liability
- Medtronic Hit With NJ Suit Over Shoddy Placement Of Device
- Health Hires: Squire Patton Boggs, Lando & Anastasi, Barnes
- What Lawyers Can Learn From Kellyanne Conway
- J&J Talc Plaintiff Just Learned Key Cancer Details, Jury Hears
- Bio-Rad Agrees To $3.5M Fees In Ex-GC Firing Case
- InspireMD Beats Finder's Fee Bid Over $24M, For Now
- Spectrum Pharma Investors Sue Over Rejected FDA Advice
- Impax Investor Drops Suit Over Drug Price-Fixing Probe
- 'Puffery' Isn't Fraud, Says Drug Return Co. In $116M Case
- Andrews, Gainey To Be CytRx Stock-Pump Suit Lead Counsel
- Ex-Valeant, Philidor Execs Deny $40M Kickback Scheme
- Law360 Life Sciences Editorial Advisory Board
- Opioid Addiction Treatment Co. Pulls $150M IPO
- Merck Sued In Philly Over Shingles Vaccine Injuries
- Final Anti-Dumping Duties On Chinese Refrigerants Decided
- The Mistakes Lawyers Make When Copying And Pasting
- Tax Implications Of The Affordable Care Act Repeal
- Talc Studies Don't Merit User Warning, J&J Consultant Says
- Invokana Patients Lose Bid To Remand Kidney-Damage Suit
- High Court Overseas Patent Law Ruling Will Spur More Fights
- Atty In NFLer's Stock Scheme Says Insurer Owes For Defense
- Jana Scores Board Seats At Tiffany & Co., Bristol-Meyers
- NJ Pharma Co. Settles Bias Suit From Ex-Global Study Leader
- Cleveland Clinic Revives Heart-Disease Test Patent Row
- AbbVie Wants Out Of Testosterone MDL Before Bellwethers
- PTAB Upholds Pozen Patent In Kyle Bass Challenge
- Calif. Court Gets Automatic Funding Disclosure Right
- Fed. Circ. Provides Cautionary Tale On Markush Claiming
- Pharmacist, Wife Took In $20M Before Meningitis Outbreak
- Theranos' Arizona Lab Sanctioned For Quality Control Issues
- States' Suboxone Product-Hop Claims Fail, Indivior Says
- CPSC Agrees To Issue Toy Safety Regs After 2-Year Delay
- Mylan Can't Shield Docs In $100M Tax Fight Over Drug License
- Biotech CEO Nixes Bid To Pull Plea For Funneling Shares
- Baxter, Hospira Call Saline Price-Fixing Claims Illogical
- Pa. Judge Again Trims Essure Injury Claims Against Bayer
- Scientists Ask 11th Circ. To Nix $10.6M Fraud Conviction
- Less FDA Review May Boost Medical Device Plaintiff Awards
- Justices Limit Reach Of Law On Overseas Patent Infringement
- J&J Plaintiff Didn't Test For Cancer Risk Genes, Jury Hears
- Lidoderm Buyers, End Payors Win Cert. In Pay-For-Delay MDL
- Fed. Circ. Affirms PTAB Nix Of Depomed Drug-Release Patent
- 6th Circ. Upholds Abbott Labs' Depakote Birth Defect Win
- Immunomedics Attacks Investor Proxy Efforts In Del. Suit
- High Court Declines Czech Republic Suit Over $325M Award
- FDA Warning Wire: Pfizer Lapse Boosts Teva Blockbuster
- Deals Rumor Mill: Aramco, Toshiba, Sinochem
- Chemical Overload Killed Fresenius Patient, Jury Told
- Par Gets PTAB Review Of Afinitor Patent
- Supreme Court Won't Hear Law Firm's Avandia Fund Dispute
- Feds Push Back At Exhibits In Meningitis Murder Trial
- Syngenta MDL Class Counsel Want Other Firms To Butt Out
- Health Care Deal Predictions From '17 JP Morgan Conference
- Shkreli, Ex-Katten Atty Seek To Split Criminal Cases
- Impax Says FTC Should Pay For Withdrawn Pay-For-Delay Suit
- Supreme Court Won't Hear $308M Boston Scientific Appeal
- Jurors In Toxic Tort Litigation Take Genetics Seriously
- Del. High Court's Volcano Ruling Confirms Corwin's Potency
- How The GDPR Will Impact Life Sciences And Health Care
- 9th Circ. Doubts Timeliness Of Amgen Off-Label Sales Suit
- Jury Finds Man Traded On Inside Info About Sanofi Deal
- 4 Cos. Agree To $14.8M Deal To Clean Up Ill. Superfund Site
- Ex-Neurostar Investors Say Buyer Is Holding On To Escrow
- Biosimilar Notice Ruling 'Nonsensical,' High Court Hears
- Snapchat's $3B IPO Leads Rebounding Tech Market
- Merck Settles Long-Running Pay-For-Delay Suit
- Becton Asks Justices Not To Revive $340M Antitrust Award
- Ex-Playboy Bunny Accuses Sex Pill Maker Of Fake Promo
- Kimberly-Clark Wants Investor Suit Over Gowns Tossed
- Pharmacist Rebuts Key Testimony In Meningitis Murder Trial
- FCA Decision Tracker: Continued Interpretations Of Escobar
- Taxation With Representation: Weil, Skadden, Kirkland
- Jury Finds Chinese Scientist Guilty In Stolen Seeds Plot
- Breast Implant Fight Should Stay In Court, Brazilian Co. Says
- Amgen Hiding Biosimilar Info, Genentech Suit Says
- Echo Investors Get Fee Bid Slashed In 'Slam Dunk' Case
- Pfizer Prevails In 2 W.Va. Zoloft Birth Defect Suits
- Atty's Widow Can't Prove GSK Meant To Harm, Judge Says
- Sofia Vergara Sues Ex-Fiancé In Dispute Over Pre-Embryos
- Immunomedics Will Turn Over Sale Documents To Investors
- 11th Circ. Affirms Toss Of Dispute Over Enbrel Use
- Watson Wants Lidoderm Suit Stayed For Ruling On FTC Power
- Bugs And Hair Plagued Meningitis-Linked Pharmacy, Jury Told
- Hospital Slams Bids To Ax $10M Pepcid Patent Verdict
- Life Sciences Group Of The Year: White & Case
- 2nd Circ. Actos Ruling Boosts Pharma Antitrust Plaintiffs
- Coherus Says IP Covering Mega-Drug Humira Is 'Obvious'
- When Personal Jurisdiction And Alter Ego Collide
- Relearning The Lessons Of Korematsu's Case
- Next Steps After Broad Institute's Big Gene-Editing Patent Win
- How A General Counsel Should Think About AI: Part 2
- Dr. Reddy's Generic Infringes Aloxi Patents, Judge Rules
- J&J Tells Jury Talc Is Warning-Free, Like Alcohol, Red Meat
- PTAB Sees No Overlap In Rival Schools' Gene-Editing Patents
- Meningitis-Linked Drugmaker Was On States' Radar, Jury Told
- Ariosa Urges Fed. Circ. Not To Review AIA Estoppel Provision
- FTC Chair Says She'll Seek Balance In IP Antitrust Cases
- Sunovion Gets 2 Latuda Generics Blocked, Sues Over A 3rd
- Insurers Fight Cancer Center Dismissal Bid In Data Breach
- Ex-Cohen Milstein Attys Launch New Group At Motley Rice
- Med-Mal Jury Charge Didn't Force Verdict, NJ Panel Says
- Judge Steps Back From Lilly Investor Suit Over Ropes & Gray
- Latham Guides Integra In $1B Offer For J&J Neurosurgery Unit
- Life Sciences Group Of The Year: Mayer Brown
- How A General Counsel Should Think About AI: Part 1
- 10 Years Of MedImmune: How License Agreements Changed
- Cancer Survivor's Tissue Nearly Talc-Free, J&J Tells Jury
- Arthrex, Smith & Nephew Settle Suture Anchor Patent Row
- FDA Warning Wire: FDA Denied Docs At Chinese Plant
- Major Cos. Back New Group Aimed At Educating Public On IP
- Judge Urged To Keep Boston Scientific Mesh Cases Moving
- Immunomedics Investor Says Board Avoiding Director Election
- Roxane's PTAB Challenge To Afinitor Patent Comes Up Empty
- Hologic Expands Into Medical Aesthetics With $1.65B Buy
- Life Sciences Group Of The Year: King & Spalding
- Pfizer, Flynn Appeal £89M Fines Over UK Epilepsy Drug Prices
- Long-Arm Jurisdiction In Missouri And Beyond: Part 2
- 10 Years Of MedImmune: What Trademark Owners Learned
- Medtronic Dodges Spine Device FCA Suit, For Now
- Valeant, Ackman Ink Allergan Litigation Management Deal
- Saving Lawyers 1 Less Drink At A Time
- Illinois lawmakers propose biotechnology tax credits
- New FDA Enforcement Stats Show Shifting Targets
- DHS Must Scrutinize Bio Attacker ID Abilities, Report Says
- NJ Whistleblower Denied Shares Of States' FCA Settlements
- Long-Arm Jurisdiction In Missouri And Beyond: Part 1
- Sessions Could Further Blunt Bank Access For Pot Biz
- Deals Rumor Mill: Stada, Popeye's, Syneron
- Egalet Hit With 2nd Investor Suit Over Abuse-Deterrent Label
- Buyers Want Patent Suit Docs In Asacol Antitrust Suit
- Wellbutrin Buyers Tell 3rd Circ. Actos Ruling Bolsters Case
- Debevoise Guides Allergan In $2.47B Zeltiq Buy
- Life Sciences Group Of The Year: Goodwin Procter
- 10 Years Of MedImmune: How Patent Owners Fared
- What To Know About HHS Revised 'Common Rule'
- Lawyers Cannot Stay Silent While Trump Belittles The Courts
- Talc Lobbyists Stymied Carcinogen Classification, Jury Hears
- Del. Plaintiffs Bar Rattled By Seismic Shift In Merger Law
- Regeneron Subpoenaed Over Patient Assistance Nonprofits
- Par Can't Shake Antitrust Suit Over Vasopressin Access
- BIO, PhRMA Back Call For Fed. Circ. To Broaden AIA Estoppel
- Energy Rebound Leads Capital Markets As Health Care Fades
- Sanofi Says Amphastar, Ex-K&L Atty Doctored Evidence
- Ethicon Asks 4th Circ. To Rethink $3M Pelvic Mesh Verdict
- Sandoz Kicks Off Supreme Court Biosimilar Battle
- Fresenius Doctor Grilled Over Label On Dialysis Drug
- GSK Moves To Cut Willfulness From Reed Smith Suicide Trial
- FDA Warns Of Potential Obesity Stomach Balloon Issues
- 1st Circ. Gauges Antitrust Immunity In Enoxaparin Row
- Life Sciences Group Of The Year: Covington & Burling
- Ex-Insys Sales Boss Indicted In Fentanyl Kickback Scheme
- Fed. Circ. Clears Actavis In Generic Lialda Patent Suit
- How Tom Price Is Being Welcomed As HHS Secretary
- Marketing Basics For Solo Practitioners And Small Law Firms
- Nearly 30 Senate Dems Sign On To Scientific Integrity Bill
- 10 Years Of MedImmune: The Fed. Circ. Decisions
- Senate Confirms Price For HHS Secretary
- 9th Circ. Urged To Revive Spine Device FCA Suit
- Clovis Cancer-Drug Class Action Survives Dismissal Bid
- Feds Look To Intervene In 20-State Drug Antitrust Suit
- Wash. High Court Says Intuitive Had Duty To Warn Hospital
- J&J Hid Talc Risk For 'Love Of Money,' Jury Hears
- GCs May Increasingly Blow The Whistle After Bio-Rad Verdict
- Report Details Problems At Theranos' Arizona Lab
- Fed. Circ. OKs Invalidity Of Patent In $37.5M Greatbatch Case
- GAO Singles Out Holes In FDA Adverse Event Reporting
- Vaccines Developer Visterra Postpones $50M IPO
- AbbVie Fights Discovery Request Of Doc In Testosterone MDL
- GE Doubles Down On DQ Dispute In Incubator Patent Case
- Del. Justices Uphold Volcano's 'Irrebuttable' Merger Rule
- Big Pharma Challenges FDA's New Off-Label Rule
- USPTO Asks Fed. Circ. For Fee Awards In All Outside Suits
- Sloan Kettering Seeks More Sanctions In Drug IP Case
- Don't Overlook Pleading Challenges In State Pharma Suits
- Key Takeaways From FTC Merger Remedy Study
- Law Firm Margin Improvement: The Long Game
- Gore Must Pay Fees After Sanctions Bid Fails In IP Row
- Fresenius Drug Killed Dialysis Patient, Jury Told
- Stakes High For J&J At Start Of Latest Baby Powder Trial
- Fed. Circ. Lets Sanofi, Regeneron Sell Drug In Patent Appeal
- What To Watch As FTC Opens New Front On Generic Delays
- Kimberly-Clark, Gown Buyers Want Experts, Evidence Blocked
- Former NFL Star Sues Hair Clinic Over Use Of Likeness
- Shkreli Involved In Tech Startup Looking To Raise $1M
- FTC, Valeant See Eye-To-Eye On Paragon Divestiture
- Del. Justices Grapple With Volcano's 'Irrebuttable' Rule
- US Intervenes In Blood Pressure Drug Antitrust Suit
- Teva Sub Says It Should Also Be Cut From FTC Androgel Suit
- Pharma Rep Avoids Prison For Lying To Feds Over Kickbacks
- Pharma Co. Investors Sue After CEO Detained Over Drug Trial
- Medtronic Bone Mill Antitrust Suit Barred, 10th Circ. Says
- 1st Circ. To Size Up Antitrust Shield In Enoxaparin Row
- DOJ Criminal Division In 2016: Fraud Section Rising
- Meister Seelig Adds IP Partner From Haynes And Boone
- Justice Gorsuch And Product Liability Litigation
- Groups Sue To Block Trump's 2-For-1 Regulatory Order
- 2nd Circ. Revives Actos Antitrust Suit But Limits Scope
- 2017 Check-Up: Is Your Law Firm Positioned For Success?
- Pa. Judge Explains Bench Toss Of Paxil Birth Defect Suit
- Major Cos. Push High Court For Stricter Patent Venue Rules
- Cosmetics Trade Group Wants Out Of J&J Talc MDL
- Starboard Settlement Adds Fresh Faces To Perrigo's Board
- Another Biotech Director Arrested In Insider Trading Suit
- FDA Warning Wire: Dirty Dentures, Contact Lenses, Chocolate
- NuScience Fails To Show Atty. Malice In Trade Secrets Row
- Shire Unit Abused FDA Process With Most Filings Ever: FTC
- Lifewatch Must Turn Over Some Evidence Sought By FTC
- Posner Heaps Doubt On Glaucoma Dropper Class Claims
- Brazilian Airline Azul Leads 3 IPOs Joining Pipeline
- The Missing Key To 3rd-Party Litigation Funding
- Biomarker Exposure Tests Will Revolutionize Toxic Torts
- Trends To Watch In DOJ Cartel Investigations This Year
- What TC Heartland Could Mean For Venue In ANDA Cases
- How Stein Could Transform Sentencing For Securities Fraud
- Jury Awards Bio-Rad's Ex-GC $8M For Retaliatory Firing
- Alere Calls Abbott's Chancery Bid For Info Unfounded
- Ancestry.com To Pay $12.5M To Settle DNA Test Patent Suit
- Deadly Drugs Shipped Before Test Results Came In, Jury Told
- 2nd Circ. Resurrects TCPA Suit Over Faxed Seminar Invites
- Syringe Co. Asks Justices To Review $340M Antitrust Reversal
- Calif. AG Sues Allergan, Watson Over Pay-For-Delay Scheme
- Investors Sue Over Lilly's $960M Buy Of Migraine Drug Co.
- Monsanto Can't Escape Cities' PCBs Suit, Judge Rules
- Stemtech Pictures High Court Taking Up $1.6M Photo Case
- Stay Cymbalta Suit Until Xbox Ruling, Lilly Tells 9th Circ.
- GSK Nabs $40M Arbitral Award In Migraine Drug Row
- How PTAB Applies Mayo To Method Involving Natural Principle
- 11th Circ. Affirms CPA's Insider Trading Conviction
- Mylan Inks $96.5M Pay-For-Delay Deal With Cephalon Buyers
- Teva Facing Infringement Suit Over Generic Pain Med ANDA
- GSK Says New Claim Has No Evidence In Avandia MDL
- Derma Sciences Hit With Another Suit Over Integra Buy
- AstraZeneca Prevails In Trial Over Diabetes Drug Patent
- CVS' Shoddy Shipping Ruined Arthritis Drug, Suit Says
- GSK Refuses Judge's Order In Reed Smith Suicide Trial
- How To Ask A Jury For Money
- Express Scripts Loses Quick Win Bid In Antitrust Suit
- Hagens Berman Objects To Report On Thalidomide Suits
- Spain Opens Antitrust Proceedings Against Drugmaker Aspen
- FDA To Divulge Full Resumes Of Outside Advisers
- Wiley Rein Adds Enviro & Safety, Product Reg Attys
- Nature's Way Gets Quick Win In Ginkgo Pill Suit
- UK Enforcement Chief Warns Antitrust Probes Won't Slow
- Seyfarth Adds IP Partner To DC Litigation Group
- What Schulhauser Means For Conditional Claim Limitations
- Clearing Up The Smoke: Insurance And Marijuana
- Affirmed: Pharmacies Are Not Liable For Drug Labeling
- 11th Circ. Bats Down Atty's Fight For $1M In Billing Row
- DNA Testing Co. Balks At Class Cert. In Row Over Web Posts
- Trump Gets Scant Support On Eased FDA Oversight
- FTC Asks To Drop Par, Paddock From AndroGel Antitrust Row
- United Healthcare's Hep C Coverage Deal Gets Final OK
- FDA Warns Of Serious Allergic Reactions To Antiseptic
- Abbott Cleared Of All Claims In Depakote Birth-Defects Trial
- Lifewatch Fights FTC's Discovery Request In Marketing Suit
- Real Estate Rumors: New York Times, Apotex, Square Mile
- NY Fed. Judge Throws Out Arsenic Cleanup Suit
- Becton Can't Get Coverage For Syringe Antitrust Suit: Insurer
- Deals Rumor Mill: ChemChina, Nature's Bounty, Pfizer
- Davis Polk Partner Testifies Bio-Rad GC Didn't Back Claims
- Ardian Unloads Disinfectant Biz To Ecolab In $809M Deal
- Avandia MDL Settlement Administrator Sues Atty For $2.5M
- Biotech Co. Suspends $150M IPO, Citing Market Jitters
- Mylan Slams IRS' 'Misleading' Discovery Motion In Tax Row
- A $15M Lesson On Merger Talk Disclosure
- An Open Letter To The New FTC Chair On Pyramid Schemes
- Can Federal Agencies Reverse Course Under Trump?
- The 4 Wittiest Dissents By Gorsuch
- NY Investor Blocks Transfer Of Keryx Stock Drop Suit
- Gorsuch's Opening Words Speak Volumes About His Style
- Bio-Rad GC's Temper, Damages Claim Questioned At Trial
- REIT's $1.5B IPO Thrusts 1 Firm Ahead Of Pack In Jan.
- Senators Flirt With Nuclear Option Over High Court Pick
- HHS Ices 340B 'Mega-Guidance' Amid Regulatory Freeze
- Biotech Co. Must Face Willful Infringement, Judge Says
- Taylor-Wharton Attys, Advisers Get $4M In Ch. 11 Fees
- Similar On The Law, Gorsuch Differs From Scalia In Style
- Drug Refund Co. Slams $116M Theft Claims In Trial Opener
- Attys React To Judge Gorsuch's Supreme Court Nomination
- Deals Rumor Mill: Arqiva, Medtronic, CCC
- Mayer Brown Adds IP Partner From Clifford Chance
- J&J's Hip Verdict Appeal Attacks 'Inflammatory' Rhetoric
- Derma Sciences Hit With Suits Over $204M Integra Buy
- Benicar MDL Judge Won't Send Med Mal Suit To State Court
- Stradley Ronon Lands Ex-Pepper Hamilton IP Attorney
- The Myth Of The Forceful Mediator
- Tips For Addressing The IP Challenges Of 3-D Printing: Part 1
- Why The Supreme Court Must Revisit Personal Jurisdiction